Zobrazeno 1 - 10 of 1 210 pro vyhledávání: '"Dorp, S."'
1
Akademický článek
Significant impact of antibiotic exposure on GI-GVHD, NRM, and GRFS following allogeneic HCT with non-myeloablative Flu-TBI conditioning.
Autor: van Groningen LFJ; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.; Radboud Institute of Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., van Dorp S; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., Bremmers MEJ; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., Fazel S; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., Roeven MWH; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., Blijlevens NMA; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.; Radboud Institute of Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., van der Velden WJFM; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.; Radboud Institute of Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Publikováno v: Leukemia & lymphoma [Leuk Lymphoma] 2024 Jul; Vol. 65 (7), pp. 950-957. Date of Electronic Publication: 2024 Mar 23.
Zobrazit plný text záznamu
2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
5
Akademický článek
Tuberculosis-Associated Hemophagocytic Lymphohistiocytosis: Diagnostic Challenges and Determinants of Outcome.
Autor: Kurver L; Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands., Seers T; The Hospital for Tropical Diseases, University College London Hospitals NHS Foundation Trust, London, UK., van Dorp S; Department of Hematology, Radboud University Medical Center, Nijmegen, the Netherlands., van Crevel R; Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands., Pollara G; The Hospital for Tropical Diseases, University College London Hospitals NHS Foundation Trust, London, UK.; Division of Infection and Immunity, University College London, London, UK., van Laarhoven A; Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands.
Publikováno v: Open forum infectious diseases [Open Forum Infect Dis] 2024 Jan 11; Vol. 11 (4), pp. ofad697. Date of Electronic Publication: 2024 Jan 11 (Print Publication: 2024).
Zobrazit plný text záznamu
7
Akademický článek
Population-Based External Validation of the EASIX Scores to Predict CAR T-Cell-Related Toxicities.
Autor: de Boer JW; Department of Hematology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands., Keijzer K; Department of Hematology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands., Pennings ERA; Department of Hematology, Amsterdam UMC Location University of Amsterdam, 1007 MB Amsterdam, The Netherlands.; Cancer Center Amsterdam, 1105 AZ Amsterdam, The Netherlands.; LYMMCARE (Lymphoma and Myeloma Center Amsterdam), 1105 AZ Amsterdam, The Netherlands.; Erasmus School of Health Policy and Management, Erasmus University Rotterdam, 3062 PA Rotterdam, The Netherlands., van Doesum JA; Department of Hematology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands., Spanjaart AM; Department of Hematology, Amsterdam UMC Location University of Amsterdam, 1007 MB Amsterdam, The Netherlands.; Cancer Center Amsterdam, 1105 AZ Amsterdam, The Netherlands.; LYMMCARE (Lymphoma and Myeloma Center Amsterdam), 1105 AZ Amsterdam, The Netherlands., Jak M; Department of Hematology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands., Mutsaers PGNJ; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands., van Dorp S; Department of Hematology, Radboud University Medical Center, 6500 HB Nijmegen, The Netherlands., Vermaat JSP; Department of Hematology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands., van der Poel MWM; Department of Internal Medicine, Division of Hematology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, 6229 HX Maastricht, The Netherlands., van Dijk LV; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands., Kersten MJ; Department of Hematology, Amsterdam UMC Location University of Amsterdam, 1007 MB Amsterdam, The Netherlands.; Cancer Center Amsterdam, 1105 AZ Amsterdam, The Netherlands.; LYMMCARE (Lymphoma and Myeloma Center Amsterdam), 1105 AZ Amsterdam, The Netherlands., Niezink AGH; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands., van Meerten T; Department of Hematology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.
Publikováno v: Cancers [Cancers (Basel)] 2023 Nov 16; Vol. 15 (22). Date of Electronic Publication: 2023 Nov 16.
Zobrazit plný text záznamu
8
Akademický článek
Inflammatory reactions mimic residual or recurrent lymphoma on [18F]FDG-PET/CT after CD19-directed CAR T-cell therapy.
Autor: de Boer JW; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands., Pennings ERA; Department of Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam, The Netherlands.; LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands.; Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands., Kleinjan A; Department of Internal Medicine, Rivierenland Hospital, Tiel, The Netherlands., van Doesum JA; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands., Spanjaart AM; Department of Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam, The Netherlands.; LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands., Mutsaers PGNJ; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., Jak M; Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands., van der Poel MWM; Department of Internal Medicine, Division of Hematology, GROW school for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands., Kuipers MT; Cancer Center Amsterdam, Amsterdam, The Netherlands.; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Adam JA; Cancer Center Amsterdam, Amsterdam, The Netherlands.; Department of Radiology and Nuclear Medicine, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands., Diepstra A; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Koens L; Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands., van Dorp S; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., Vermaat JSP; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Niezink AGH; Department of Radiation Oncology, University Medical Center Groningen, Groningen, The Netherlands., Kersten MJ; Department of Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam, The Netherlands.; LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands., van Meerten T; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands.
Publikováno v: Blood advances [Blood Adv] 2023 Nov 14; Vol. 7 (21), pp. 6710-6716.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje